Clinical Trials
3 trialsNCT01798485 2016-07-01
Galaxy 2
Synta Pharmaceuticals Corp.
Phase 3 Terminated
NCT01562015 2015-05-20
CHIARA
Synta Pharmaceuticals Corp.
Phase 2 Completed
NCT01031225 2014-09-19
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Synta Pharmaceuticals Corp.
Phase 2 Completed